Reports for TARO PHARMACEUTICALS INC
Company Name
TARO PHARMACEUTICALS INC
Totals |
||
Shortage reports |
503 |
|
| Actual shortage: | 26 (5%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 477 (95%) | |
Discontinuation Reports |
17 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 17 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
267 (51%) |
|
Overdue reports |
14 (54%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TARO-DASATINIB | 140MG | TABLET | Resolved | 2022-11-04 | 2023-02-01 | 173727 |
| TARO-CAPECITABINE | 150MG | TABLET | Resolved | 2018-10-16 | 2019-02-04 | 64413 |
| TARO-CAPECITABINE | 150MG | TABLET | Resolved | 2018-10-16 | 2019-02-04 | 64416 |
| TARO-CAPECITABINE | 150MG | TABLET | Resolved | 2019-06-17 | 2019-08-06 | 86700 |
| TARO-CAPECITABINE | 150MG | TABLET | Resolved | 2019-10-11 | 2020-01-28 | 96356 |
| TARO-CAPECITABINE | 150MG | TABLET | Resolved | 2020-01-04 | 2020-01-28 | 102332 |
| TARO-CAPECITABINE | 150MG | TABLET | Resolved | 2020-04-03 | 2020-05-27 | 110912 |
| TARO-CAPECITABINE | 150MG | TABLET | Resolved | 2021-05-01 | 2021-05-04 | 138575 |
| TARO-CAPECITABINE | 150MG | TABLET | Resolved | 2021-10-13 | 2022-11-03 | 147098 |
| TARO-CAPECITABINE | 150MG | TABLET | Resolved | 2022-04-12 | 2022-11-15 | 158611 |
| TARO-CAPECITABINE | 150MG | TABLET | Resolved | 2022-04-12 | 2022-11-03 | 158647 |
| VIADERM KC CRM | 1MG 100000UNIT 0.25MG 2.5MG | CREAM | Resolved | 2019-07-05 | 2019-08-06 | 88692 |
| VIADERM KC CRM | 1MG 100000UNIT 0.25MG 2.5MG | CREAM | Resolved | 2019-07-05 | 2019-08-06 | 88695 |
| VIADERM KC CRM | 1MG 100000UNIT 0.25MG 2.5MG | CREAM | Resolved | 2019-08-19 | 2019-09-14 | 91817 |
| VIADERM KC CRM | 1MG 100000UNIT 0.25MG 2.5MG | CREAM | Resolved | 2019-09-13 | 2019-09-23 | 93898 |
| VIADERM KC CRM | 1MG 100000UNIT 0.25MG 2.5MG | CREAM | Resolved | 2019-09-13 | 2019-09-23 | 93901 |
| VIADERM KC CRM | 1MG 100000UNIT 0.25MG 2.5MG | CREAM | Resolved | 2019-11-01 | 2020-01-13 | 97836 |
| VIADERM KC CRM | 1MG 100000UNIT 0.25MG 2.5MG | CREAM | Resolved | 2019-11-01 | 2020-01-04 | 97839 |
| VIADERM KC CRM | 1MG 100000UNIT 0.25MG 2.5MG | CREAM | Resolved | 2019-11-26 | 2020-01-04 | 99739 |
| VIADERM KC CRM | 1MG 100000UNIT 0.25MG 2.5MG | CREAM | Resolved | 2020-01-04 | 2020-05-14 | 102353 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TARO-AMCINONIDE | 0.1% | CREAM | Discontinued | 2020-05-14 | 2020-05-14 | 115031 |
| TARO-TEMOZOLOMIDE | 100MG | CAPSULE | Discontinued | 2020-08-28 | 2020-08-28 | 123258 |
| TARO-WARFARIN | 10MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80067 |
| TARO-DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Discontinued | 2020-02-02 | 2020-02-02 | 105030 |
| VIADERM KC ONT | 1MG 100000UNIT 0.25MG 2.5MG | OINTMENT | Discontinued | 2019-08-09 | 2019-08-10 | 91315 |
| TARO-WARFARIN | 2.5MG | TABLET | Discontinued | 2019-11-01 | 2019-11-02 | 97862 |
| TARO-WARFARIN | 2.5MG | TABLET | Discontinued | 2021-11-26 | 2021-11-26 | 150094 |
| MICOZOLE | 2% | CREAM | Discontinued | 2022-11-04 | 2022-11-04 | 173736 |
| TARO-TEMOZOLOMIDE | 20MG | CAPSULE | Discontinued | 2020-08-28 | 2020-08-28 | 123255 |
| TARO-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-02-02 | 2020-02-02 | 105033 |
| TARO-WARFARIN | 2MG | TABLET | Discontinued | 2021-08-24 | 2021-08-24 | 144558 |
| TARO-WARFARIN | 3MG | TABLET | Discontinued | 2021-11-26 | 2021-11-26 | 150097 |
| TARO-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2020-02-02 | 2020-02-02 | 105036 |
| TARO-TEMOZOLOMIDE | 5MG | CAPSULE | Discontinued | 2020-08-28 | 2020-08-28 | 123252 |
| TARO-WARFARIN | 5MG | TABLET | Discontinued | 2021-12-07 | 2021-12-07 | 150693 |
| TARO-WARFARIN | 5MG | TABLET | Discontinued | 2023-09-25 | 2023-09-25 | 205189 |
| TARO-WARFARIN | 7.5MG | TABLET | Discontinued | 2022-11-04 | 2022-11-04 | 173760 |
Showing 1 to 17 of 17